From Drughunters winner to neuropsychologist

Every year, the Drughunters competition inspires high school students all over Denmark and ignites an interest that can pave the way for the neuroscience talents of tomorrow, such as Charlotte Amalie Børglum Sørensen.

This is Lundbeck

We are one of the only pharmaceutical companies in the world focusing exclusively on brain diseases, and we’re set apart by our specialization. 

With more than 70 years of neuroscience expertise, Lundbeck has developed and commercialized some of the world's most widely prescribed therapies for brain diseases.

Employee spotlight

When the COVID-19 lockdown announcement came in March 2020, and thousands of colleagues around the globe transitioned to remote work in a matter of days, the pressure was on IT like never before.

Come join us in making a difference to patients worldwide.

Explore the latest financial developments at Lundbeck.

a better life for people with brain diseases

At Lundbeck, we see patients as people and are committed to support the person behind the disease. 

Partnering

The complexity of brain diseases requires a concerted effort. We are committed to develop new and better treatment options from innovations born in house or externally.

jason F. houston on working at Lundbeck

Advocacy Makes the Difference

Lundbeck at a glance

100

countries where our products are sold

5,600

employees supporting our purpose

1915

year Lundbeck was founded